ALZHEIMER'S DISEASE(AD)

This study tested an experimental pill called ABBV-552 to see if it could help control symptoms in people with mild Alzheimer's disease. About 240 participants, aged 50-90, took either the drug or a placebo (a dummy pill) daily for 12 weeks. Researchers checked for safety, change…

This study tested an experimental drug called ABBV-916 in people with early Alzheimer's disease. About 195 participants received monthly IV infusions to see if the drug was safe, how it moved through the body, and if it could reduce harmful amyloid plaques in the brain. The trial…

This study tested if a temporary nerve-blocking injection in the neck, given alongside standard Alzheimer's medications, could help improve thinking, memory, and daily life for people with the disease. Researchers compared two groups over six months: one received the injection pr…

This study tested a new type of blood test designed to help diagnose Alzheimer's disease. Researchers collected blood and urine samples from 150 people, including those with Alzheimer's, other brain diseases, and healthy individuals. The goal was to see if a special chip that pre…

This study tested whether a new computer software called 'SCALE PET' helps doctors interpret brain scans more accurately when looking for signs of Alzheimer's disease. Four doctors reviewed old brain scan images from 190 people, sometimes using the software for help and sometimes…

This study tested whether a 4-week treatment using graphene far-infrared technology could improve thinking skills and mental well-being in older adults experiencing memory problems. It involved 126 participants, some with mild concerns and others with more significant impairment,…

This study aimed to understand how Alzheimer's disease develops by tracking changes in the brain over time. It followed over 1,100 older adults, some healthy, some with mild memory issues, and some with early Alzheimer's, for up to five years. Researchers used brain scans, memory…